ArticleGeneral hospital psychiatry
Clinical predictors of repeat intramuscular medication administration for acute agitation: A retrospective cohort study.
Article in General hospital psychiatry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIntramuscular (IM) antipsychotics are frequently used for acute agitation in psychiatric settings. While prior studies have focused on onset of sedation and adverse effects, the need for repeat IM medication, an important real-world marker of treatment effectiveness, has not been well characterized.
methodsThis retrospective study included adult patients who received IM haloperidol lactate or IM olanzapine for acute agitation between January 2020 and November 2022 at an academic medical center. The primary outcome was repeat IM medication administration within 24 h. Secondary analyses examined time to repeat administration. Sociodemographic, clinical, and treatment-related variables were compared. Multivariable logistic regression and Cox proportional hazards models were used to identify independent associations.
resultsAmong 342 patients, 81 (23.7%) required repeat IM medication. Antipsychotic agent was not associated with repeat administration. In adjusted analyses, repeat medication was independently associated with co-administration of diphenhydramine (OR = 2.18), history of violence (OR = 1.88), and psychotic disorders (OR = 2.24), while substance use history (OR = 0.48) and inpatient setting (OR = 0.50) were associated with lower odds. Similar findings were observed in time-to-event analyses. Greater prior hospitalizations were associated with shorter time to repeat medication. Benzodiazepine co-administration was not independently associated with outcomes.
conclusionsRepeat IM medication for acute agitation is common and appears to be driven primarily by patient-level factors rather than choice of antipsychotic agent. These findings highlight the importance of underlying illness severity and agitation phenotype in determining treatment response. Identifying patients at higher risk for escalation may inform targeted management strategies and resource allocation in acute psychiatric care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.